ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Survival"

  • 2016 American Transplant Congress

    Chronic Infection by Hepatitis C Virus and the Development of Transplant Glomerulopathy.

    D. Regidor,1 S. Alexandru,5 M. Martínez,3 N. Polanco,4 E. González,4 A. Serrano,2 J. Morales.4

    1Nephrology, H.Virgen de la Salud, Toledo, Spain; 2Immunology, Instituto de Investigación H. Doce de Octubre, Madrid, Spain; 3Pathology, H.Doce de Octubre, Madrid, Spain; 4Nephrology, H.Doce de Octubre, Madrid, Spain; 5Nephrology, H.Rey Juan Carlos, Madrid, Spain.

    OBJETIVE: To demonstrate that chronic infection with the hepatitis C virus (HCV) is a risk factor for the development of transplant glomerulopathy in a large…
  • 2016 American Transplant Congress

    The Effect of Body Mass Index on Lung Transplant Outcomes.

    M. Kashem,1 A. Shiose,1 J. Abraham,1 N. Dean,1 S. Breves,1 F. Cordova,2 N. Patel,2 T. Yoshizumi,1 G. Criner,2 Y. Toyoda.1

    1Division of Cardiovascular Surgery, Temple University, Philadelphia, PA; 2Department of Thoracic Medicine and Surgery, Temple University, Philadelphia, PA.

    Background: Lung transplant (LTx) has the potential to effectively extend the life expectancy for patients with end-stage lung disease. Both high and low body mass…
  • 2016 American Transplant Congress

    When Liver Transplants and Procurement Occur at One Location – A National Study of Graft Survivals.

    J. Ortiz,1 N. Koizumi,2 C. Kwon,2 Y. Zhang,2 C. Ortiz.3

    1University of Toledo, Toledo, OH; 2George Mason University, Fairfax, VA; 3Bucknell University, Lewisburg, PA.

    Organ procurement and placement processes entail complex scheduling, logistics and other administrative challenges, especially when organs travel outside the procuring Organ Procurement Organization (OPO) area.…
  • 2016 American Transplant Congress

    Sociodemographic and Comorbidity Differences Between Dialysis, Waitlisted and Transplant Patients in the UK: Findings from the ATTOM Study.

    D. Wu,1 M. Robb,2 C. Watson,3 R. Ravanan,4 J. Forsythe,1 A. Bradley,3 G. Oniscu.1

    1Royal Infirmary of Edinburgh, Edinburgh, United Kingdom; 2NHSBT, Bristol, United Kingdom; 3University of Cambridge, Cambridge, United Kingdom; 4Southmead Hospital, Bristol, United Kingdom.

    IntroductionAccess to Transplantation and Transplant Outcome Measures (ATTOM) is a prospective cohort study involving all 72 UK renal units, investigating factors affecting access to and…
  • 2016 American Transplant Congress

    Impact of Pre-Existing Comorbidities on Long-Term Patient and Graft Survival in Kidney Transplant Recipients.

    F. Halleck, D. Khadzhynov, L. Lehner, E. Schrezenmeier, M. Duerr, A. Kleinsteuber, K. Budde, O. Staeck.

    Nephrology, Charité University, Berlin, Germany.

    BACKGROUND Outcomes of patients with end-stage renal disease are largely affected by their comorbidities. Detailed data evaluating the impact of pre-transplant comorbidities on the long-term…
  • 2016 American Transplant Congress

    Controlled Cardiac Death Donor Program for Kidney Transplantation – Spanish Multicenter Experience with Two Years of Follow-Up.

    J. Portoles,1 M. Perez-Saez,2 D. Hernandez-Marrero,2 O. Lafuente,1 F. Diekmann,2 N. Maruri Kareaga,2 M. Rodriguez-Ferrero,2 F. Llamas,2 M. Mazuecos,2 J. Juega,2 E. Melilli,2 A. Rodriguez-Benot,2 A. Alonso,2 J. Pascual.2

    1Nephrology, U.H.Puerta de Hierro-RedinRen, Majadahonda, Spain; 2Nephrology, SENTRA-GEODAS Group, Madrid, Spain.

    Background: Controlled donation after cardiac death (cDCD) programs are running in several countries for years. National transplant organization (ONT) has developed a nation-wide program in…
  • 2016 American Transplant Congress

    How Small Is Too Small: A Comparison of Access and Survival by Weight in Pediatric Liver Transplant Recipients.

    E. Steen, R. Cotton, A. Rana.

    Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX.

    Introduction: Orthotopic liver transplantation is a well-established treatment modality for a wide variety of pediatric illness. With its associated technical challenges, paucity of size-matched allografts,…
  • 2016 American Transplant Congress

    Pre-Transplant Loco-Regional Therapy for Hepatocellular Carcinoma and Post-Transplant Outcomes: A National Study.

    M. Nazzal,1 J. Chen,1 K. Lentine,1 M. Schnitzler,1 J. Tuttle-Newhall,2 C. Varma,1 A. Taha,1 A. Said,1 H. Xiao,1 H. Randall.1

    1Saint Louis Univ, Saint Louis; 2East Carolina Univ, Greenville.

    Currently most transplant centers use loco-regional therapy to bridge liver transplant (LT) candidates with hepatocellular carcinoma (HCC). However, limited data are available to support the…
  • 2016 American Transplant Congress

    Kidney Survival Outcomes in Combined Intestinal-Kidney Transplant: An Analysis of the UNOS/OPTN Database 2000-2014.

    A. Sharfuddin, T. Taber, M. Yaqub, I. Moinuddin, A. Khalil, O. Adebiyi, M. Mujtaba.

    Medicine/Nephrology, Indiana University, Indianapolis.

    Background: Intestinal transplants (isolated/modified/multi-visceral) carry a high morbidity and mortality. Kidney outcomes after combined intestinal (IT) with kidney transplant (CIKT) remain largely uninvestigated.Methods: The UNOS…
  • 2016 American Transplant Congress

    Delayed Graft Function (DGF) Doesn't Affect Adversely the Long-Term Survival of Renal Transplantations (RT) from Uncontrolled Donation After Cardiac Death (UDCD) as Compared with RT from Standard Criteria Donor (SCD).

    M. Molina,1 J. Cabrera,2 E. Gonzalez,1 E. Gutierrez,1 E. Morales,1 E. Hernandez,1 M. Praga,1 A. Andres.1

    1Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain; 2Nephrology, Hospital de Clínicas, Montevideo, Uruguay.

    INTRODUCTION: DGF is a well-known risk factor for long-term kidney survival in RT. DGF hasn't been evaluated in RT from SCD and from UDCD donors.AIM:…
  • « Previous Page
  • 1
  • …
  • 50
  • 51
  • 52
  • 53
  • 54
  • …
  • 66
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences